EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of HPV Adult Vaccination on Serum Anti-Müllerian Hormone Levels: Paired Measurements in a Retrospective Cohort

Ali Can Gunes, Muhammed Onur Atakul, Utku Akgor, Gonca Ozten Dere, Murat Cengiz, Haticegul Tuncer, Betul Gungor Serin iD, Mehmet Kabacam iD, Hakan Aydinli iD, Murat Gultekin

Vaccines · 03.03.2026 · 14 (3) · 233

DOI: 10.3390/vaccines14030233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vaccines, online erschienen am 03.03.2026. Verfasst von Ali Can Gunes und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Faculty of Medicine, Hacettepe University, Ankara 06100, Turkey. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Concerns that human papillomavirus (HPV) vaccination may adversely affect ovarian reserve contribute to vaccine hesitancy, yet longitudinal data with paired anti-Müllerian hormone (AMH) measurements are limited. We evaluated whether HPV vaccination was associated with short-term changes in AMH compared with an unvaccinated control group.

Methods

In this retrospective cohort, women aged 18–45 years who completed a three-dose 9-valent HPV vaccination (Gardasil 9®, Merck Sharp & Dohme LLC, West Point/Pennsylvania/USA) schedule and had AMH measured before dose 1 and after dose 3 were compared with unvaccinated controls who had two AMH measurements during routine gynecologic evaluation. AMH change was summarized as absolute change (ΔAMH), percent change, and log change. To compare rates of AMH change while accounting for heterogeneous follow-up and confounding, AMH was analyzed on the natural log scale using a linear mixed-effects model with a random intercept for participant and fixed effects for time (years), group, and a time × group interaction, adjusted for age, current smoking, gravidity, and parity. Annual percent change was derived from model coefficients. Prespecified sensitivity analyses repeated the primary model under follow-up restrictions and after restricting baseline AMH to 1.0–5.0 ng/mL.

Results

The cohort included 158 vaccinated and 106 control women. Baseline AMH was similar between groups (median 1.88 vs. 1.94 ng/mL), while the follow-up interval was shorter in vaccinated women (6.7 vs. 8.9 months). Unadjusted AMH decline was smaller in vaccinated women (median ΔAMH −0.13 vs. −0.27 ng/mL; p = 0.015; median percent change −10.9% vs. −20.6%; p = 0.006). In the adjusted mixed-effects model, controls showed an estimated AMH decline of −27.6% per year (95% CI −35.5% to −18.7%; p < 0.001). The time × group interaction was positive (β = 0.170, 95% CI 0.027 to 0.312; p = 0.020), corresponding to a slope ratio of 1.185 (95% CI 1.02–1.366) and an implied annual change of −14.2% per year (95% CI −21.0% to −6.7%) in vaccinated women. Results were broadly consistent in follow-up-restricted sensitivity analyses; however, in the baseline AMH 1.0–5.0 ng/mL restricted cohort (vaccinated n = 82, control n = 67), the interaction was attenuated and not statistically significant (β = 0.082, p = 0.237).

Conclusions

In this retrospective cohort with paired AMH measurements, HPV vaccination was not associated with evidence of clinically meaningful short-term impairment in ovarian reserve as assessed by AMH. Observed differences in AMH alterations were modest and should be interpreted cautiously, given residual confounding, measurement variability, and reduced precision in restricted-cohort analyses.

Schlagwörter

Stichwörter der Autor:innen

HPV vaccinationanti-Mullerian hormonehuman papillomavirusovarian reservevaccine safety

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Faculty of Medicine, Hacettepe University, Ankara 06100, Turkey.
  • Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Faculty of Medicine, Hacettepe University, Ankara 06100, Turkey.
  • Faculty of Medicine, Hacettepe University, Ankara 06230, Turkey.

ORCID-Profile: Betul Gungor Serin, Mehmet Kabacam, Hakan Aydinli

Zitieren

APA

Gunes, A. C., Atakul, M. O., Akgor, U., Ozten Dere, G., Cengiz, M., Tuncer, H., Gungor Serin, B., Kabacam, M., Aydinli, H., & Gultekin, M. (2026). Effect of HPV Adult Vaccination on Serum Anti-Müllerian Hormone Levels: Paired Measurements in a Retrospective Cohort. Vaccines, 14(3), 233. https://doi.org/10.3390/vaccines14030233

Vancouver

Gunes AC, Atakul MO, Akgor U, Ozten Dere G, Cengiz M, Tuncer H, et al. Effect of HPV Adult Vaccination on Serum Anti-Müllerian Hormone Levels: Paired Measurements in a Retrospective Cohort. Vaccines. 2026;14(3):233. doi:10.3390/vaccines14030233

BibTeX
@article{Gunes2026,
  author = {Gunes, Ali Can and Atakul, Muhammed Onur and Akgor, Utku and Ozten Dere, Gonca and Cengiz, Murat and Tuncer, Haticegul and Gungor Serin, Betul and Kabacam, Mehmet and Aydinli, Hakan and Gultekin, Murat},
  title = {Effect of HPV Adult Vaccination on Serum Anti-Müllerian Hormone Levels: Paired Measurements in a Retrospective Cohort},
  journal = {Vaccines},
  year = {2026},
  volume = {14},
  number = {3},
  pages = {233},
  doi = {10.3390/vaccines14030233}
}
Kostenlos starten →